^
BIOMARKER:
BRAF V600K
i
Other names: BRAF, B-raf proto-oncogene, B-raf proto-oncogene, Serine/threonine kinase, V-Raf murine sarcoma viral oncogene homolog B, Serine/threonine-protein kinase B-Raf, Proto-oncogene B-Raf, BRAF1, RAFB1, B-raf proto-oncogene Serine/threonine-protein kinase, Murine sarcoma viral (V-Raf) oncogene homolog B1, B-raf serine/threonine-protein, 94 KDa B-raf protein, B-RAF1
Entrez ID:
Related biomarkers:
BRAF V600K
Melanoma
trametinib + dabrafenib
Sensitive
:
A1
BRAF V600K
Melanoma
trametinib
Sensitive
:
A1
BRAF V600K
Melanoma
binimetinib + encorafenib
Sensitive
:
A1
BRAF V600K
Melanoma
vemurafenib + cobimetinib
Sensitive
:
A1
BRAF V600K
Cutaneous Melanoma
trametinib + dabrafenib
Sensitive
:
A2
BRAF V600K
Cutaneous Melanoma
pembrolizumab
Sensitive
:
A2
BRAF V600K
Cutaneous Melanoma
nivolumab
Sensitive
:
A2
BRAF V600K
Melanoma
dabrafenib
Sensitive
:
A2
BRAF V600K
Cutaneous Melanoma
binimetinib + encorafenib
Sensitive
:
A2
BRAF V600K
Melanoma
pembrolizumab
Sensitive
:
B
BRAF V600K
Melanoma
encorafenib
Sensitive
:
B
BRAF V600K
Cutaneous Melanoma
trametinib
Sensitive
:
C1
BRAF V600K
Solid Tumor
binimetinib + encorafenib
Sensitive
:
C1
BRAF V600K
Melanoma
pembrolizumab + trametinib + dabrafenib
Sensitive
:
C2
BRAF V600K
Melanoma
vemurafenib + atezolizumab + cobimetinib
Sensitive
:
C2
BRAF V600K
Solid Tumor
trametinib + dabrafenib + AT13387
Sensitive
:
C2
BRAF V600K
Melanoma
vemurafenib
Sensitive
:
C2
BRAF V600K
Melanoma
BGB-283
Sensitive
:
C3
BRAF V600K
Melanoma
nivolumab
Sensitive
:
C3
BRAF V600K
Melanoma
9-ING-41
Sensitive
:
C3
BRAF V600K
Melanoma
PD1 inhibitor + CTLA4 inhibitor
Sensitive
:
C3
VERI is free for non-commercial use, no login needed.
Content on this site is for research purposes only and is not intended  to be a substitute for medical advice.
For commercial access, including additional premium features, please contact us.
By using VERI, you are agreeing to our